Stuart Kaiser, UBS Head of Equity Derivatives Research, joined Yahoo Finance Live to discuss today’s market action as investors digest the election results and COVID-19 vaccine news from Pfizer. …read more
Source:: Yahoo Finance
Stuart Kaiser, UBS Head of Equity Derivatives Research, joined Yahoo Finance Live to discuss today’s market action as investors digest the election results and COVID-19 vaccine news from Pfizer. …read more
Source:: Yahoo Finance
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.